This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ferguson has held corporate and strategic development roles in a number of health care organizations since 2004, including his most recent position as vice president of business development at Guardian Pharmacy. Our Hospice of South Central Indiana Appoints MedicalDirector. Agape Care Group Appoints M&A VP.
About the Authors: Lead author, Chad Kollas, MD, serves as the MedicalDirector for Palliative and Supportive Care at the Orlando Health Cancer Institute in Orlando, FL. Dr. Kollas provided testimony at a 2004 Congressional Hearing on OxyContin. Kollas provided testimony at a 2004 Congressional Hearing on OxyContin.
By 2007, the Washington State Agency MedicalDirectors Group (AMDG), which included several eventual PROP members (23), published an “Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain (26) that introduced the concept of hard dosing thresholds for opioid analgesics, which was later incorporated into the 2016 Guideline (2, 3).
Franklin also served on the Washington State Agency MedicalDirectors Group (AMDG) via the Washington State Department of Labor and Industries (9). About the Authors Lead author, Chad Kollas , serves as the MedicalDirector for Palliative and Supportive Care at the Orlando Health Cancer Institute in Orlando, FL.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content